Table 2.
Main clinical characteristics of the study subjects at December 31, 2013
| Characteristics | N | |
|---|---|---|
| BMI, Kg/cm2 | 1247 | 33.5 ± 5.5 |
| BMI categorical | ||
| <30 Kg/cm2 | 347 (27.8%) | |
| 30-35 Kg/cm2 | 483 (38.6%) | |
| ≥35 Kg/cm2 | 420 (33.6%) | |
| Waist circumference, cm | 1237 | 101.3 ± 13.1 |
| Blood pressure, mmHg | 1247 | |
| Sistolic | 125.4 ± 15.8 | |
| Diastolic | 78.5 ± 9.5 | |
| Above 140/90 mmHg | 60 (4.8%) | |
| Below 140/90 mmHg | 1190 (95.2%) | |
| Heart rate, bpm | 1243 | 67.6 ± 10.4 |
| Uric acid | 1163 | 5.2 ± 1.4 |
| Fibrinogen, mg/dl | 1129 | 335 ± 59 |
| C-reactive protein | 1160 | 0.3 [0.1-0.5] |
| Total cholesterol, mg/dl | 1165 | 215.1 ± 41 |
| HDL | 59.2 ± 15.5 | |
| LDL | 134.7 ± 36.3 | |
| Triglyceride | 1164 | 107 [77–145.5] |
| Serum creatinine, mg/dL | 1165 | 0.8 ± 0.3 |
| AST, U/I | 1159 | 19 [16–23] |
| ALT, U/I | 1160 | 21 [16–30.5] |
| Gamma-Glutamyltransferase, IU/L | 1162 | 19 [13–30] |
| Glucose | 1155 | 92 [86–101] |
| Homocysteine | 1151 | 10.4 [8.6–12.7] |
| TSH | 1163 | 1.7 [1.2–2.5] |
| Glycated hemoglobin, mmol/mol | 1159 | 39 [36.6–43] |
| Postprandial glycaemia, mg/dl | 1162 | 99 [90–112] |
| Insulin level | 1158 | 12.3 [8.8–18] |
| 2-hour post glucose insulin level | 1155 | 46.4 [27.6–73] |
| Urinary pH | 1144 | 5.6 ± 0.7 |
| Emocrome | 1156 | |
| White blood cells | 6.8 ± 1.7 | |
| Red blood cells | 4.8 ± 0.4 | |
| Hemoglobin | 13.8 ± 1.4 | |
| Hematocrit | 40.7 ± 3.4 | |
| Mean Corpuscolar Volume | 85.1 ± 6.4 | |
| Platelets | 249.7 ± 59 |
Continuous variable are expressed as mean ± standard deviation (SD) or as median [first quartile-third quartile] if not normally distributed; discrete variables are expressed as counts (%).